Eurepa V 0.5/0.2 Mg Tablet (10 Tab)

EUREPA V 0.5/0.2 MG TABLET

Name: Eurepa V 0.5/0.2 MG Tablet (Brand Name)

Composition: Eurepa V 0.5/0.2 MG Tablet contains a combination of two active ingredients: Repaglinide (0.5mg) and Voglibose (0.2mg).

Uses: This medicine is primarily used in the management of Type 2 diabetes mellitus. It is prescribed to help control high blood sugar levels, especially after meals, when diet, exercise, and other similar anti-diabetic medications alone are not sufficient to achieve adequate glycemic control.

Dosage and Administration: Eurepa V Tablet should be taken orally, exactly as directed by your doctor. It is typically administered immediately before or up to 30 minutes before each main meal. The tablet should be swallowed whole with water and not chewed, crushed, or broken. Do not discontinue the medication abruptly without consulting your doctor, as this may lead to an increase in blood sugar levels. If a dose is missed, do not take a double dose; instead, wait for your next meal and take it as usual.

Side Effects: Common side effects may include hypoglycemia (low blood sugar level), bloating, diarrhea, headache, fatigue, dizziness, stomach pain, skin rash, fever, muscle pain, heartburn, nausea, and vomiting. If any of these symptoms worsen or persist, consult your doctor.

Precautions:

• Eurepa V is contraindicated if you are allergic to repaglinide or voglibose, have a severe liver disorder, Type 1 diabetes, metabolic acidosis (such as diabetic ketoacidosis), or severe infection after surgery.
• Caution is advised in patients with kidney problems, heart disorders, large intestine ulcers, or thyroid disease.
• It is generally considered unsafe to use during pregnancy and is probably unsafe during breastfeeding.
• Avoid alcohol consumption as it can affect blood glucose levels and increase the risk of hypoglycemia.
• The medicine is not recommended for individuals under 18 or over 75 years of age.
• Regular monitoring of blood sugar levels is important during treatment. This medicine may cause dizziness or hypoglycemia, which can impair your ability to drive or operate machinery.

Storage: Store Eurepa V 0.5/0.2 MG Tablet in a cool and dry place, away from direct sunlight and moisture, at a temperature below 30°C. Keep it out of the reach of children.

What is EUREPA V 0.5/0.2 MG TABLET used for?

EUREPA V 0.5/0.2 MG TABLET is primarily used to manage Type 2 Diabetes Mellitus. It helps control high blood sugar levels, especially after meals, when diet and exercise alone or other similar medicines are insufficient.

How does EUREPA V 0.5/0.2 MG TABLET work?

This medicine contains two active ingredients: Repaglinide and Voglibose. Repaglinide stimulates the pancreas to release more insulin quickly after meals. Voglibose works by slowing down the digestion and absorption of carbohydrates in the small intestine, which helps prevent sudden spikes in blood glucose levels after eating. Together, they effectively manage post-meal blood sugar.

What is the usual dosage for EUREPA V 0.5/0.2 MG TABLET?

EUREPA V 0.5/0.2 MG TABLET is typically taken orally, usually one tablet before meals (approximately 15 to 30 minutes before each main meal) or just after meals. The exact dosage and duration of treatment are determined by your doctor based on your individual condition and response to the medication.

What are the possible side effects of EUREPA V 0.5/0.2 MG TABLET?

Common side effects can include hypoglycemia (low blood sugar level), flatulence, diarrhea, stomach pain, headache, fatigue, dizziness, skin rash, nausea, vomiting, and heartburn. If any of these symptoms worsen or persist, it's important to consult your doctor.

Is EUREPA V 0.5/0.2 MG TABLET safe during pregnancy or breastfeeding?

EUREPA V 0.5/0.2 MG TABLET is generally considered unsafe for use during pregnancy as it may harm the unborn baby. It is also probably unsafe to use while breastfeeding, as it can be harmful to the newborn. Your doctor may recommend alternative treatments or advise stopping breastfeeding.

Can EUREPA V 0.5/0.2 MG TABLET be taken with other medications?

This medicine can interact with several other medications. It may increase the risk of low blood sugar if taken with other anti-diabetic medicines like insulin or sulfonylureas. Interactions can also occur with cholesterol-lowering medicines (e.g., gemfibrozil), certain antibiotics (e.g., ketoconazole, clarithromycin, trimethoprim), anti-tuberculosis medicines (e.g., rifampicin), immunosuppressants (e.g., ciclosporin), steroids, anti-hypertensive medicines (e.g., captopril), and cardiac glycosides (e.g., digoxin). Always inform your doctor about all medications, supplements, and herbal products you are taking.

What precautions should be taken while taking EUREPA V 0.5/0.2 MG TABLET?

This medication is not suitable for everyone. It should not be used if you have Type 1 diabetes, severe liver disease, or certain gastrointestinal disorders like inflammatory bowel disease, colonic ulceration, or partial intestinal obstruction. Caution is advised for patients with kidney or liver problems, and dosage adjustments may be necessary. It is important to monitor your blood sugar levels regularly and to carry sugary food to manage potential hypoglycemia symptoms. Avoid alcohol consumption, as it can increase the risk of low blood sugar. EUREPA V 0.5/0.2 MG TABLET may cause dizziness or drowsiness, so exercise caution when driving or operating machinery. It is generally not recommended for children under 18 or adults over 75 years of age. Do not stop taking this medication abruptly without consulting your doctor.

What happens if a dose of EUREPA V 0.5/0.2 MG TABLET is missed?

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one, as this can lead to an increased risk of side effects like low blood sugar.

How should EUREPA V 0.5/0.2 MG TABLET be stored?

EUREPA V 0.5/0.2 MG TABLET should be stored in a cool and dry place, typically below 30°C, away from direct sunlight and moisture. Keep it out of the sight and reach of children.